HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells-Reference-Cited by-同舟云学术

HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells

Published:2017-02-17 Issue:16 Volume:8 Page:27314-27327
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tang Lanlan¹,Chai Wenwen²,Ye Fanghua¹,Yu Yan¹,Cao Lizhi¹,Yang Minghua¹,Xie Min¹,Yang Liangchun¹

Affiliation:

1. Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, People's Republic of China

2. Department of Nuclear Medicine, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410008, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide;Annals of Hematology;2024-04-29

2. Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis;Molecular Medicine;2024-03-16

3. HMGB1 in the interplay between autophagy and apoptosis in cancer;Cancer Letters;2024-01

4. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia;Frontiers in Immunology;2023-03-31

5. Roles of PADI4 in the expression of cytokines involved in inflammation and adhesion in differentiated NB4 cells treated with ATRA;Experimental and Therapeutic Medicine;2023-01-31